Skip to main content

Gassert Chad's Form 4 filing

Ani Pharmaceuticals IncANIP · filed Apr 2, 2024

Accession no.
0001871002-24-000008
Filed
Apr 2, 2024
Trade date
Apr 1, 2024
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 1 non-derivative transaction. Open-market sales total $1.34M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Gassert ChadCIK 0001871002Officer (SVP - CORP. DEV. & STRATEGY)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 1, 2024Common StockSSaleDisposed−20,000$67.25F2−$1,345,000253,226Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The shares were sold in multiple trades at prices ranging from $66.50 to $69.05. The price reported above reflects the weighted average sales price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)